Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05488847 · ClinicalTrials.gov registry record · Phase 4
Opioid-Free Pain Protocol After Shoulder Arthroplasty
A Phase 4 study of Shoulder Pain and Shoulder Arthropathy, sponsored by Henry Ford Health System.
- Active
- Registry status
- Phase 4
- Development phase
- 83
- Enrollment target
- 1
- Study location
NCT05488847: Active Phase 4 study of Shoulder Pain and Shoulder Arthropathy, sponsored by Henry Ford Health System.
NCT05488847 is a Phase 4 study of Shoulder Pain and Shoulder Arthropathy that is active but no longer recruiting, run by Henry Ford Health System. The registered enrollment target is 83 participants, below the 98-participant average among 27 other Shoulder Pain trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05488847, a Phase 4 study of Shoulder Pain and Shoulder Arthropathy, is active but no longer recruiting, sponsored by Henry Ford Health System.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 83 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized, single blinded, clinical trial aims to investigate the efficacy of a multimodal pain control regimen for shoulder arthroplasty. Patients who receive a multimodal pain control regimen alone (study group) will be compared to patients who receive a multimodal pain control regimen plus a standard prescription of an opioid containing medication (comparison group). The primary outcome is average daily Numerical Rating Scale (NRS) pain score in the first 10 days after surgery. We hypothesize that there will be no significant difference in the primary outcome between the two groups.
Primary Outcome
Patients record pain levels using a Visual analog scale for 10 days post-operatively. On each day, patients report their pain level via an automated text messaging service in the morning, afternoon, and the evening. A mean pain level is calculated from all scores reported by a patient in the first 10 days postoperatively. Patients will use a 0-10 scale along with visuals to indicate their level of pain with 0 being no pain at all and 10 being the worst pain possible. Lower scores indicate better
Conditions Studied
Interventions
- DRUG Acetaminophen
- DRUG Dexamethasone
- DRUG Celecoxib
- DRUG Tramadol
- DRUG Pregabalin
Study Locations (1)
Michigan
- Henry Ford Health - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2022-06-25 |
| Est. Completion | 2026-09-01 |
| Phase | Phase 4 |
What the registry record for NCT05488847 still lists
NCT05488847 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 98-participant average among 27 other Shoulder Pain trials with a reported enrollment target (15% lower).
The record links to 2 conditions, with Shoulder Pain appearing as the primary indexed condition, and to 5 interventions - of which Acetaminophen is the first listed.
NCT05488847 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT05488847 about?
NCT05488847 is a clinical study titled "Opioid-Free Pain Protocol After Shoulder Arthroplasty". This randomized, single blinded, clinical trial aims to investigate the efficacy of a multimodal pain control regimen for shoulder arthroplasty. Patients who receive a multimodal pain control regimen alone (study group) will be compared to patients who receive a multimodal pain control regimen plus ...
What is the current status of trial NCT05488847?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 83 participants. The study started on 2022-06-25. Estimated completion is 2026-09-01.
What conditions does trial NCT05488847 study?
This clinical trial studies the following conditions: Shoulder Pain, Shoulder Arthropathy.
What interventions are being tested in trial NCT05488847?
The interventions under investigation include: Acetaminophen (DRUG), Dexamethasone (DRUG), Celecoxib (DRUG), Tramadol (DRUG), Pregabalin (DRUG).
Who is sponsoring clinical trial NCT05488847?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05488847 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shoulder Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05488847's enrollment target sits among peer trials
83 11th of 27 higher than 17 of 27 other Shoulder Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Shoulder Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Connective Tissue Matrix for Rotator Cuff Tendinopathy
ACTIVE NOT RECRUITING · Phase 4
-
Liposomal Bupivacaine vs Dexamethasone ISB
COMPLETED · Phase 4
-
Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve Blockade for Arthroscopic Rotator Cuff Repair
COMPLETED · Phase 4
-
Shoulder RFA Pilot Study
RECRUITING
-
MDR - Comprehensive Primary Revision Stems PMCF
RECRUITING
-
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI